Fingerprint
Dive into the research topics of 'Phase i clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase i clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
Clive S. Zent, Brian J. Smith, Zuhair K. Ballas, James E. Wooldridge, Brian K. Link, Timothy G. Call, Tait D. Shanafelt, Deborah A. Bowen, Neil E. Kay, Thomas E. Witzig, George J. Weiner
Research output: Contribution to journal › Article › peer-review
69
Scopus
citations